Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$50,000.00
Nov 27, 2020
217594
217594
Engage consultants for two clinical studies
$102,763.00
Nov 27, 2020
For-profit organization
CytoGnomix Inc is partnering with the Ontario Institute of Evaluative and Clinical Sciences (IC/ES) to obtain access to the geographic COVID-19 daily incidence data and geostatistics software licenses.
$1,464,715.00
Nov 25, 2020
For-profit organization
COVID19 Rapid Response - BOLD-100: A first in class therapeutic for COVID-19
961802
BOLD-100 is a first-in-class, clinical-stage investigational therapy being developed for the treatment of patients with cancer and viral infections, including COVID-19.
$250,000,000.00
Nov 21, 2020
Not-for-profit organization or charity
Global Financing Facility for Women, Children and Adolescents (GFF) 2021-25
7424631 P007457001
Project activities include: (1) supporting countries in developing individual RMNCAH-N investment cases to align sources of financing to national priorities; (2) clinical interventions such as increasing access to health services and health facilities from the pre-pregnancy stage onwards for women, newborns and children; (3) health systems interventions such as strengthening health systems, strengthening health information systems and increasing access to medical products/technologies; and (4) multi-sectoral interventions in multiple sectors such as education, nutrition, and water and sanitation and strengthening of CRVS systems.
$69,990.00
Nov 10, 2020
Academia
AI-Enabled cough detection and multimodal contactless vital signs monitoring
960943
The Recipient will collaborate with the NRC to integrate the models within a system for clinical validation. The COVID-19 cough will be explored to understand if there are unique features.
$800,000.00
Nov 9, 2020
Not-for-profit organization or charity
Protecting Sexual and Reproductive Health and Rights in the Philippines - Response to COVID-19
7423744 P009592001
Project activities include: (1) improving access to comprehensive SRHR services for women and girls by providing family planning, ante-natal and post-natal services, screening for sexually transmitted infections, SGBV detection and counselling, and cervical cancer screening and treatment; (2) organizing capacity building for local women’s rights organizations (WROs), and better coordination of WROs, civil society organizations, community mobilizers (CMs) and community health providers (CHPs) who work to lead community outreach and education activities; (3) providing training to clinic staff, CMs and CHPs to better detect SGBV, offering counselling and providing referrals in-person, online or through a telehealth system; (4) disseminating COVID-19 information and resources by CMs and CHPs; and (5) engaging clinic staff with community leaders and government stakeholders to better coordinate information sharing and SRHR, SGBV and COVID-19 responses.
$160,198.00
Nov 6, 2020
Academia
Bioprocessing for viral vectored vaccines: an accelerated development approach leading to cGMP manufacturing of candidate vaccines for COVID-19
961152
Vectored-vaccine candidates are among the most advanced SARS-CoV-2 in the 38 clinical evaluations (WHO, Draft landscape of COVID-19 candidate vaccines, Sept. 24, 2020).
$229,983.00
Nov 6, 2020
Academia
Bioprocessing for viral vectored vaccines: an accelerated development approach leading to cGMP manufacturing of candidate vaccines for COVID-19
961152
Vectored-vaccine candidates are among the most advanced SARS-CoV-2 in the 38 clinical evaluations (WHO, Draft landscape of COVID-19 candidate vaccines, Sept. 24, 2020).
$160,198.00
Nov 6, 2020
Academia
Bioprocessing for viral vectored vaccines: an accelerated development approach leading to cGMP manufacturing of candidate vaccines for COVID-19
961152
Vectored-vaccine candidates are among the most advanced SARS-CoV-2 in the 38 clinical evaluations (WHO, Draft landscape of COVID-19 candidate vaccines, Sept. 24, 2020).
$81,795.00
Nov 6, 2020
Not-for-profit organization or charity
Advanced enzymatic activity testing of anti-COVID19 ACE2-based biotherapeutics
961435
This Project involves pre-clinical studies of ACE2-Fc variants with potential therapeutic properties against COVID-19.